This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
"At a time when voters and their elected officials nationwide are re-evaluating state and federal marijuana policies, it is inconceivable that government agencies are unwilling to provide data on the estimated costs and scope of federal marijuana prohibition in America."
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report , the agency and its law enforcement partners confiscated an estimated four million marijuana plants in 2019 – up from 2.8 It was the second-lowest number of arrests reported by the DEA in the past decade.
Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. Understanding current drug scheduling for cannabis The DEA classifies drugs, substances, and certain chemicals used to make drugs into five distinct categories or “schedules.”
What’s more, synthesized Delta-9 THC is present in many of these products, despite being prohibited in both California’s cannabis and hemp programs. In response to its growing popularity, the DEA announced in 2016 that kratom would be placed in the restrictive Schedule I along with cannabis.
Members of the House Energy and Commerce Subcommittee on Health today held a legislative hearing, “ Cannabis Policies for the New Decade ,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. He continued: “The fact of the matter is that legalization and regulation work.
This Wednesday, January 15th, at 10 am EST, the House Energy and Commerce Subcommittee on Health will hold a legislative hearing entitled “Cannabis Policies for the New Decade.” ” This marks the first time that members of the Energy and Commerce Committee will hear and debate issues specific to marijuana policy reform.
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Given the DEA’s stonewalling, forcing their hand is a notable achievement. Dozens of Applications”. .
The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. According to the data published in the DEA’s yearly Domestic Cannabis Eradication/Suppression Program Statistical Report, approximately 4.54
Drug Enforcement Agency (DEA) made far fewer cannabis-related arrests in 2019 than in previous years. Let’s take a closer look at what DEA data reveals. Per the DEA’s Domestic Cannabis Eradication/Suppression Program (DCESP) , a whopping 4,003,194 cannabis plants were seized and destroyed in 2019.
The hemp industry is up in arms over the USDA’s interim rules establishing a domestic hemp program. Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. 3% Total THC. Your Comments Matter.
Well, the DEA just released its 2020 National Drug Threat Assessment, and the report is full of stats on the United States’ most popular illegal addictions, new trends in intoxicants, and foreign trade — a.k.a. The US sourced 92 percent of its heroin from Mexico in 2019, according to product analyzed by a DEA tracing program.
Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.
Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. As of July 2022, 38 states in America have legalized medical cannabis, and 19 states and the District of Columbia have established recreational cannabis programs.
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Program Statistical Report, agents and their partners confiscated approximately 5.53 million plants via its domestic eradication program. Federal law enforcement agents and their partners seized over 5.5 million plants were confiscated).
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.
Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. Wisconsin Wisconsin has no state medical cannabis program and no licensed medical Marijuana dispensaries. Wyoming Wyoming is among the few states without a medical cannabis program. year prison sentence.
Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). It would transfer primary agency jurisdiction over cannabis from the DEA to the FDA, TTB, and ATF. Restorative Justice and Opportunity Programs.
LegitScript, the global leader in merchant and product certification and monitoring in the e-commerce and payment sectors, has launched a new certification program for legally compliant CBD products and websites. LegitScript’s CEO, John Horton, said the program will bring transparency and structure to the CBD industry.
” This fee — which is designed to support social equity programs — is required to convert up to three medical cannabis dispensaries into dual medical-recreational facilities. However, it’s important to note that — according to the Marijuana Policy Project — each applicant would be required to pay a fee of $3 million.
The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law. One area that could be quickly improved is in the sourcing of research-grade marijuana.
The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. POPLAR will publish original law and policy research. CR: Can you describe the existing landscape of psychedelics research?
Alexandria Ocasio-Cortez (D-NY) called for decriminalizing the use of and research on psychedelics, as well as comprehensive marijuana legalization, in a video message played for a drug policy reform conference on Thursday. Read full report: [link].
This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes.
other known or potential challenges by the participation of States or producers in the domestic hemp production program. other known or potential challenges by the participation of States or producers in the domestic hemp production program. It’s probably too early to tell whether this HR 5587 has a chance to become law.
. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.
It also includes comprehensive restorative justice provisions, including grants, loans, and other funding programs for disadvantaged and minority businesses, record expungement, petitions for resentencing, and other measures intended to repair the decades of harm caused by the War on Drugs. Cannabis above 0.3% Source: [link].
If successful, these rule changes would allow hemp to be grown within four miles of marijuana cultivation, and remove the requirement that hemp farmers get permission from the DEA before importing hemp seeds. One open issue is how to pay for the hemp-licensing program that is compliant with the 2018 Farm Bill.
A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. There must be a concerted effort by the FDA and DEA to address the public health crisis spawned by the proliferation of unregulated designer drugs being sold under the guise of hemp.
In October, Senator Mitch McConnell directed the DEA to figure out how to distinguish hemp from marijuana. Several northeastern states tried to coordinate their marijuana policies. However, protections for state-legal medical marijuana programs were once again included in the recently passed funding bill.
DEA gave financial and technical assistance to the FDLE for cannabis control, but no money went to the spraying of paraquat. FDLE states that it is their plan to keep controlling cannabis with or without the DEA’s assistance.
Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Authors Tracy Gallegos and Neville M. Rescheduling cannabis will not necessarily facilitate clinical research.
But times are changing, and leaders are now calling for revamped policies on psilocybin, hemp, and cannabis research for varying reasons. In February 2021, a lawsuit was filed against the DEA for prohibiting access for others aside from the University of Mississippi to cultivate cannabis for research purposes.
Such actions by the federal will create some very difficult paths because of policy distinctions arising from individual rights, public protections, commercial activities, health and safety, use of resources, etc.]. We are not going to attempt to tackle the myriad policy issues of this alternative, but we do have some observations.
According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Nonetheless, with the increasing legalization of medical cannabis, many veterans and interest groups have asked the government to change its policies.
Mississippians have also voted to establish a medical marijuana program, but that legislation is still pending.). But the Drug Enforcement Administration (DEA) is equipped to mete out maximum penalties of up to five years in prison and a $250,000 fine for anyone transporting less than 50kg of marijuana—even for a first-time offense.
This stems from the fact that despite the ongoing legalization of both recreational and medical marijuana at the state level, cannabis is still classified as a Schedule I substance by the DEA, along with substances such as heroin, cocaine, opioids and methamphetamine.
Clinton’s drug policy record while in office has been widely criticized by advocates. He also rejected requests to lift a federal ban on harm reduction policies like syringe exchange programs.
In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. McGuireWoods LLP. Newsworthy Highlights. Happy 2022! Montana: As of Jan. Louisiana: As of Jan.
Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). Lack of write-ups could suggest to investigators that there is no compliance program at all, thereby making the company’s license suspension or revocation more likely.
Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). Lack of write-ups could suggest to investigators that there is no compliance program at all, thereby making the company’s license suspension or revocation more likely.
Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). Lack of write-ups could suggest to investigators that there is no compliance program at all, thereby making the company’s license suspension or revocation more likely.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content